Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Cell Death Differ 17(8):1230-7 (2010) PMID 20168332
The possibility of reprogramming adult somatic cells into pluripotent stem cells (iPSCs) has generated a renewed interest into stem cell research and promises to overcome several key issues, including the ethical concerns of using human embryonic stem cells and the difficulty of obtaining large numbers of adult stem cells (Belmonte et al., Nat Rev Genet, 2009). This approach is also not free from challenges like the mechanism of the reprogramming process, which has yet to be elucidated, and the warranties for safety of generated pluripotent cells, especially in view of their possible therapeutic use. Very recently, several new reprogramming methods have surfaced, which seem to be more appropriate than genetic reprogramming. Particularly, chemically induced pluripotent cells (CiPSs), obtained with recombinant proteins or small synthetic molecules, may represent a valid approach, simpler and possibly safer than the other ones.
DOI: 10.1038/cdd.2010.14
Version: za2963e q8za2 q8zbf q8zc3 q8zd5 q8zeb q8zf7 q8zg0